Exploration for novel inhibitors showing back-to-front approach against VEGFR-2 kinase domain (4AG8) employing molecular docking mechanism and molecular dynamics simulations

Abstract

BackgroundAngiogenesis is a process of formation of new blood vessels and is an important criteria demonstrated by cancer cells. Over a period of time, these cancer cells infect the other parts of the healthy body by a process called progression. The objective of the present article is to identify a drug molecule that inhibits angiogenesis and progression.MethodsIn this pursuit, ligand based pharmacophore virtual screening was employed, generating a pharmacophore model, Hypo1 consisting of four features. Furthermore, this Hypo1 was validated recruiting, Fischer’s randomization, test set method and decoy set method. Later, Hypo1 was allowed to screen databases such as Maybridge, Chembridge, Asinex and NCI and were further filtered by ADMET filters and Lipinski’s Rule of Five. A total of 699 molecules that passed the above criteria, were challenged against 4AG8, an angiogenic drug target employing GOLD v5.2.2.ResultsThe results rendered by molecular docking, DFT and the MD simulations showed only one molecule (Hit) obeyed the back-to-front approach. This molecule displayed a dock score of 89.77, involving the amino acids, Glu885 and Cys919, Asp1046, respectively and additionally formed several important hydrophobic interactions. Furthermore, the identified lead molecule showed interactions with key residues when challenged with CDK2 protein, 1URW.ConclusionThe lead candidate showed several interactions with the crucial residues of both the targets. Furthermore, we speculate that the residues Cys919 and Leu83 are important in the development of dual inhibitor. Therefore, the identified lead molecule can act as a potential inhibitor for angiogenesis and progression.Electronic supplementary materialThe online version of this article (10.1186/s12885-018-4050-1) contains supplementary material, which is available to authorized users.

Comparative Proteomic Profiling of Tumor-Associated Proteins in Human Gastric Cancer Cells Treated with Pectolinarigenin

“…Molecular docking studies impart knowledge on the binding affinities between the protein and the ligand correspondingly, which determine the quintessential binding modes of a ligand [ 18 ]. For the current investigation, the ligand coordinates were drawn from the template and the key residues were marked for all the atoms around 10 Å.…”

Discovery of Potential Inhibitors of Squalene Synthase from Traditional Chinese Medicine Based on Virtual Screening and In Vitro Evaluation of Lipid-Lowering Effect

“…It makes sense and contributes to the whole paper for the discovery of the potential compounds. Actually, 30 ns might still be a little short, but literatures have showed it could also give key information for molecular modeling [ 53 , 54 ].…”

Discovery of Non-Peptidic Compounds against Chagas Disease Applying Pharmacophore Guided Molecular Modelling Approaches

“…Molecular dynamics studies were widely applied to delineate on the molecular movement, predict the enzyme mechanism and further to comprehend on the complex assemblies. MD simulations additionally impart knowledge on the behavior of the small molecules with its protein counterpart at the atomistic level [45,46,47]. For the current investigation, MD was employed to assess the stability of the target and the ligand complexes and were studied in terms of RMSD and the potential energies recruiting GROningen MAchine for Chemical Simulations (GROMACS v5.0.6).…”